戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 homa as well as tropical spastic paraparesis/HTLV-1-associated myelopathy.
2 etiologic agent of adult T-cell leukemia and HTLV-1-associated myelopathy.
3 gic agent of adult T-cell leukemia (ATL) and HTLV-1 associated myelopathy, also called tropical spast
4 ia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy, among other disorders.
5           Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy (HAM) is an inflammatory c
6 ality due to adult T-cell leukemia/lymphoma, HTLV-1-associated myelopathy (HAM), and other inflammato
7 s (HTLV-1) that is implicated in the disease HTLV-1-associated myelopathy (HAM/TSP).
8                                              HTLV-1-associated myelopathy (HAM; HTLV-1 is human T-lym
9 ia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy in about 5% of infected ind
10 atory disease of the central nervous system, HTLV-1-associated myelopathy, in ~0.3% to 4% of them, va
11 vivo samples of tropical spastic paraparesis-HTLV-1-associated myelopathy patients contain a Lys at p
12           Human T lymphotropic virus type 1 (HTLV-1) -associated myelopathy/tropic spastic paraparesi
13                                  Five of six HTLV-1-associated myelopathy/tropic spastic paraparesis
14 nt of adult T-cell leukemia and lymphoma and HTLV-1-associated myelopathy-tropical spastic paraparesi
15 result in adult T-cell leukemia/lymphoma and HTLV-1 associated-myelopathy/tropical spastic paraparesi
16 h as human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic parapares
17 ents with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic parapares
18           Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic parapares
19 ies, including human T-lymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic parapares
20      Human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic parapares
21 y of an asymptomatic carrier or patient with HTLV-1-associated myelopathy/tropical spastic paraparesi
22 causative agent of adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesi
23 ses, including the neuroinflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesi
24 ive agent of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesi
25  agent of adult T-cell leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesi
26 TT were more frequent in 12 individuals with HTLV-1-associated myelopathy/tropical spastic paraparesi
27  with two immunologically distinct diseases: HTLV-1-associated myelopathy/tropical spastic paraparesi
28 the progression of adult T cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesi
29 -mediated inflammatory conditions, including HTLV-1-associated myelopathy/tropical spastic paraparesi
30            Finally, the inflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesi
31 s of lymphocyte kinetics are associated with HTLV-1-associated myelopathy/tropical spastic paraparesi
32 ntenance of the proviral load and determines HTLV-1-associated myelopathy/tropical spastic paraparesi
33 s, including adult T cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesi
34  1 (HTLV-1) can result in the development of HTLV-1-associated myelopathy/tropical spastic paraparesi
35                     Our analysis showed that HTLV-1-associated myelopathy/tropical spastic paraparesi
36 ding the chronic neurological disease termed HTLV-1-associated myelopathy/tropical spastic paraparesi
37 HTLV-1) results in adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesi
38  keratoconjunctivitis sicca in patients with HTLV-1-associated myelopathy/tropical spastic paraparesi
39 nflammation in the spinal cord, resulting in HTLV-1-associated myelopathy/tropical spastic paraparesi
40 +) T-cell frequency, and disease severity of HTLV-1-associated myelopathy/tropical spastic paraparesi
41 ociated with adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesi
42 for adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesi
43 cal agent of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesi
44 l blood lymphocytes (PBL) from patients with HTLV-1-associated myelopathy/tropical spastic paraparesi
45 ogressive neurodegenerative disease known as HTLV-1-associated myelopathy/tropical spastic paraparesi
46 ma (ATLL) and the neuroinflammatory disease, HTLV-1-associated myelopathy/tropical spastic paraparesi
47 or adult T-cell leukemia/lymphoma (ATLL) and HTLV-1-associated myelopathy/tropical spastic paraparesi
48 tropic virus type 1 (HTLV-1) is the agent of HTLV-1-associated myelopathy/tropical spastic paraparesi
49 d with a chronic neurological disease termed HTLV-1-associated myelopathy/tropical spastic paraperesi
50 rative disorder tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
51 s, including tropical spastic paraparesis or HTLV-1-associated myelopathy (TSP/HAM).